Search

Scott Lippman Phones & Addresses

  • 8659 Falcon Green Dr, West Palm Bch, FL 33412 (847) 980-6605
  • West Palm Beach, FL
  • Coconut Creek, FL
  • Mundelein, IL
  • Houston, TX
  • Highland Beach, FL
  • Fort Lauderdale, FL
  • Vernon Hills, IL
  • Long Grove, IL
  • Pesotum, IL
  • 106 Sandalwood Dr, Houston, TX 77024 (817) 354-1921

Work

Company: MD ANDERSON CANCER CENTER Address: 1515 Holcombe Blvd, Houston, TX 77030 Phones: (713) 792-2121 (713) 794-5492

Education

School / High School: Johns Hopkins Univ Sch Of Med 1981

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Hematology, 1988

Specialities

Hematology • Medical Oncology • Oncology

Professional Records

Medicine Doctors

Scott Lippman Photo 1

Dr. Scott M Lippman, La Jolla CA - MD (Doctor of Medicine)

View page
Specialties:
Hematology
Medical Oncology
Oncology
Address:
3855 Health Sciences Dr, La Jolla, CA 92093
(858) 822-1222 (Phone)

1515 Holcombe Blvd Suite 432, Houston, TX 77030
(713) 792-6161 (Phone), (713) 745-2012 (Fax)

1515 Holcombe Blvd, Houston, TX 77030

MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston, TX 77030
(713) 792-2121 (Phone), (713) 794-5492 (Fax)
Certifications:
Hematology, 1988
Internal Medicine, 1987
Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
3855 Health Sciences Dr, La Jolla, CA 92093

1515 Holcombe Blvd Suite 432, Houston, TX 77030

1515 Holcombe Blvd, Houston, TX 77030

MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston, TX 77030

The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Boulevard, Houston, TX 77030
Education:
Medical School
Johns Hopkins Univ Sch Of Med
Graduated: 1981
Medical School
The Johns Hopkins Hospital
Graduated: 1981
Medical School
Los Angeles County Harbor - UCLA Medical Center
Graduated: 1981
Medical School
Stanford Med Ctr
Graduated: 1981
Medical School
U Ariz Hlth Scis Ctr
Graduated: 1981
Scott Lippman Photo 2

Scott Michael Lippman, Houston TX

View page
Specialties:
Internal Medicine
Hematology
Medical Oncology
Hematology & Oncology
Hematology
Work:
MD Anderson Cancer Ctr
1515 Holcombe Blvd, Houston, TX 77030
Education:
Johns Hopkins University (1981)
Scott Lippman Photo 3

Scott M Lippman, Houston TX

View page
Specialties:
Oncologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
University Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)
Stanford Hospital & Clinics - Fellowship - Hematology
Los Angeles County Harbor-UCLA Medical Center - Residency - Internal Medicine
Johns Hopkins Hospital - Internship - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Scott Michael Lippman
Scott Lippman MD
Internist
1515 Holcombe Blvd, Houston, TX 77030
(713) 745-5439
Scott M. Lippman
Medical Doctor
University of Texas System
Management Consulting Services College/University
1515 Holcombe Blvd, Houston, TX 77030
(713) 792-5017

Publications

Isbn (Books And Publications)

Head and Neck Cancer: Emerging Perspectives

View page
Author

Scott M. Lippman

ISBN #

0122399900

Us Patents

Biomarkers For Response To Tyrosine Kinase Pathway Inhibitors In Cancer

View page
US Patent:
20130230511, Sep 5, 2013
Filed:
Feb 4, 2013
Appl. No.:
13/758728
Inventors:
Ignacio I. WISTUBA - Houston TX, US
Monique B. NILSSON - Sugar Land TX, US
Lauren A. BYERS - Houston TX, US
Ximing TANG - Houston TX, US
Fei YANG - Houston TX, US
Edward KIM - Houston TX, US
Anne S. TSAO - Houston TX, US
Scott M. LIPPMAN - Houston TX, US
Waun Ki HONG - Houston TX, US
Roy S. HERBST - Houston TX, US
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
G01N 33/74
A61K 39/395
A61K 31/506
A61K 31/4439
C12Q 1/68
A61K 31/4045
US Classification:
4241331, 435 723, 435 611, 514414, 51425218, 514338
Abstract:
Copy number gains detected in tumors and associated with drug sensitivity and resistance in vivo and in vitro can be used as biomarkers to select, predict and monitor drug treatment outcomes in cancer patients treated with tyrosine kinase inhibitors. Methods to identify patients with NSCLC or other malignancies who are more likely to benefit from tyrosine kinase inhibitors such as VEGF or VEGFR inhibitors when used either as monotherapy or in combination with other therapies such as chemotherapy or EGFR inhibitors, and who are in the advanced stages of disease and/or who have undergone adjuvant therapy are also provided herein.
Scott M Lippman from West Palm Beach, FL, age ~63 Get Report